Giammarco Raponi

Pubblicazioni

Titolo Pubblicato in Anno
The antimicrobial potential of adarotene derivatives against Staphylococcus aureus strains BIOORGANIC CHEMISTRY 2024
Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit BMC INFECTIOUS DISEASES 2024
Anti-Biofilm Activity of Oleacein and Oleocanthal from Extra-Virgin Olive Oil toward Pseudomonas aeruginosa INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
In vivo evolution to hypermucoviscosity and ceftazidime/avibactam resistance in a liver abscess caused by Klebsiella pneumoniae sequence type 512 MSPHERE 2024
High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study JOURNAL OF FUNGI 2023
Ceftazidime-avibactam resistance in Klebsiella pneumoniae sequence type 37: a decade of persistence and concealed evolution MICROBIAL GENOMICS 2023
Topical antibiotic prophylaxis before intravitreal injections: a pilot study GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 2023
The Impact of Alcohol Consumption and Oral Microbiota on Upper Aerodigestive Tract Carcinomas: A Pilot Study ANTIOXIDANTS 2023
Multiplicity of blaKPC genes and pKpQIL plasmid plasticity in the development of ceftazidime-avibactam and Meropenem coresistance in Klebsiella pneumoniae sequence type 307 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 2023
Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy. Broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital ANTIBIOTICS 2023
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study OPEN FORUM INFECTIOUS DISEASES 2023
Atopic dermatitis-derived Staphylococcus aureus strains: what makes them special in the interplay with the host FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY 2023
Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy EMERGING INFECTIOUS DISEASES 2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2023
The effect of the electromagnetic field on metabolic-active bacterial biofilm experimentallyinduced on titanium dental implants NEW MICROBIOLOGICA 2023
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2022
Alcohol and head and neck cancer: updates on the role of oxidative stress, genetic, epigenetics, oral microbiota, antioxidants, and alkylating agents ANTIOXIDANTS 2022
Exposure to b‐LED light while exerting antimicrobial activity on Gram‐negative and ‐positive bacteria promotes transient EMT‐like changes and growth arrest in keratinocytes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
The antimicrobial peptide Esc(1-21) synergizes with colistin in inhibiting the growth and in killing multidrug resistant Acinetobacter baumannii strains ANTIBIOTICS 2022
Extra Virgin Olive Oil-Based Green Formulations With Promising Antimicrobial Activity Against Drug-Resistant Isolates FRONTIERS IN PHARMACOLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma